Endogenous opiates and behavior: 2005
RJ Bodnar, GE Klein - Peptides, 2006 - Elsevier
This paper is the 28th consecutive installment of the annual review of research concerning
the endogenous opioid system, now spanning over a quarter-century of research. It …
the endogenous opioid system, now spanning over a quarter-century of research. It …
30 years of dynorphins—new insights on their functions in neuropsychiatric diseases
C Schwarzer - Pharmacology & therapeutics, 2009 - Elsevier
Since the first description of their opioid properties three decades ago, dynorphins have
increasingly been thought to play a regulatory role in numerous functional pathways of the …
increasingly been thought to play a regulatory role in numerous functional pathways of the …
Drug management of visceral pain: concepts from basic research
MP Davis - Pain research and treatment, 2012 - Wiley Online Library
Visceral pain is experienced by 40% of the population, and 28% of cancer patients suffer
from pain arising from intra‐abdominal metastasis or from treatment. Neuroanatomy of …
from pain arising from intra‐abdominal metastasis or from treatment. Neuroanatomy of …
Analgesic efficacy of peripheral κ-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective …
L Arendt-Nielsen, AE Olesen, C Staahl… - The Journal of the …, 2009 - pubs.asahq.org
Background Peripherally selective opioids may be beneficial in visceral pain management
due to absence of centrally mediated side effects. The objectives of this study were:(1) to …
due to absence of centrally mediated side effects. The objectives of this study were:(1) to …
Revisiting oxycodone analgesia: a review and hypothesis
X Ruan, KF Mancuso, AD Kaye - Anesthesiology …, 2017 - anesthesiology.theclinics.com
Oxycodone, a semisynthetic opioid analgesic, is widely used in clinical practice. Oxycodone
was first synthesized from thebaine in Germany in 1917. 1 For decades, researchers have …
was first synthesized from thebaine in Germany in 1917. 1 For decades, researchers have …
New treatments for IBS
IBS is a common disorder that affects approximately 5–20% of the populations of Western
countries; the main symptoms are abdominal pain and erratic, altered bowel habits, often …
countries; the main symptoms are abdominal pain and erratic, altered bowel habits, often …
Adverse effects of repeated, intravenous morphine on recovery after spinal cord injury in young, male rats are blocked by a kappa opioid receptor antagonist
J Rau, A Hemphill, K Araguz, R Cunningham… - Journal of …, 2022 - liebertpub.com
Immediately following spinal cord injury (SCI) patients experience pain associated with
injury to the spinal cord and nerves as well as with accompanying peripheral injuries. This …
injury to the spinal cord and nerves as well as with accompanying peripheral injuries. This …
Opiate-induced analgesia: contributions from mu, delta and kappa opioid receptors mouse mutants
C Gaveriaux-Ruff - Current pharmaceutical design, 2013 - ingentaconnect.com
The three opioid receptors, mu, delta and kappa all mediate analgesia, and knockout mice
with opioid receptor deletion have proven unique tools to investigate in vivo opioid …
with opioid receptor deletion have proven unique tools to investigate in vivo opioid …
Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications
Opioids are one of the most prescribed drug classes for treating acute pain. However,
chronic use is often associated with tolerance as well as debilitating side effects, including …
chronic use is often associated with tolerance as well as debilitating side effects, including …
Exploration of the SAR connection between morphinan-and arylacetamide-based κ opioid receptor (κOR) agonists using the strategy of bridging
X Liu, S Jiang, L Kong, R Ye, L Xiao, X Xu… - ACS Chemical …, 2021 - ACS Publications
κ opioid receptor (κOR) is a subtype of opioid receptors, and there are two major κOR
agonists currently available, morphinans and arylacetamides, which are structurally distinct …
agonists currently available, morphinans and arylacetamides, which are structurally distinct …